
In the wake of the MHRA's safety data review leading to the recall of pholcodine-containing medicines in the UK*, a burning question came to my mind: Could proactive Quality Assurance (QA) practices, including early signal detection and collaboration with healthcare providers for patient insights, have prevented the need for such widespread recalls and averted widespread…